default author photo

Roni Nitecki Wilke

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

174

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Perioperative Outcomes in Gynecologic Pelvic Exenteration Before and after Implementation of an Enhanced Recovery after Surgery Program

Number of pages: 29 Posted: 04 Jul 2024
Sarah P. Huepenbecker, Pamela Soliman, Larissa A. Meyer, Maria D. Iniesta, Gary B. Chisholm, Jolyn S. Taylor, Roni Nitecki Wilke and Nicole D. Fleming
University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 126 (572,948)

Abstract:

Loading...

Enhanced Recovery After Surgery, pelvic exenteration, gynecologic surgery, surgical outcomes

2.

Oral cyclophosphamide combined with bevacizumab in recurrent heavily pretreated ovarian cancer

Number of pages: 22 Posted: 06 Nov 2025
Mostafa F. Eyada, Victoria Michael, Shrina Patel, Jeffrey Andrew How, Roni Nitecki Wilke, Amir A. Jazaeri, Nicole D. Fleming, Pamela Soliman, Anil Sood, Shannon N. Westin and Travis T. Sims
affiliation not provided to SSRN, McGovern Medical School at UTHealth, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine and affiliation not provided to SSRN
Downloads 48 (1,170,409)

Abstract:

Loading...

Recurrent ovarian cancer, High-grade serous ovarian cancer (HGSOC), Platinum resistant ovarian cancer (PROC), Cyclophosphamide, Bevacizumab.